欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0893/001
药品名称Oxaliplatin 5 mg/ml Concentrate for Solution for Infusion
活性成分
    • oxaliplatin 5.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Fresenius Kabi Austria GmbH . Hafnerstrasse 36 8055 Graz Austria RMS change from UK/H/4134/001 UNITED KINGDOM
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 18727/0012-0030
    • Belgium (BE)
    • Luxembourg (LU)
    • Sweden (SE)
      Oxaliplatin Fresenius Kabi
    • Latvia (LV)
    • Lithuania (LT)
      Oxaliplatin Kabi 5 mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      OXALIPLATIN KABI 5MG/ML
    • Romania (RO)
      Oxaliplatin Kabi 5 mg/ml concentrat pentru solutie perfuzabila
    • Slovenia (SI)
许可日期2010/12/11
最近更新日期2024/03/21
药物ATC编码
    • L01XA03 oxaliplatin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase